Jun Wang

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Emergency Department

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

High Throughput

Top Venues

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Wang, Daniel Lam, Jeffrey Yang, Longqin Hu
Discovery of mobocertinib, a new irreversible tyrosine kinase inhibitor indicated for the treatment of non-small-cell lung cancer harboring EGFR exon 20 insertion mutations. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 31 (10) (2022)